Novel Arterial Reconstruction Policy in Simultaneous pancreas-kidney Transplantation; A randomized clinical trial

Autor: Hassan Karar, Mojtaba Shafiekhani, Mohamad Mahdi Mahmoudi, Nazanin Azadeh, Alireza Shamsaeefar, Sahar Sohrabi Nazari, Mehran Jafari, Kiarash Ashrafzadeh, Maryam Esmaeili, Saman Nikeghbalian, Hamed Nikoupour
Rok vydání: 2023
DOI: 10.21203/rs.3.rs-2391149/v1
Popis: Introduction Simultaneous pancreas kidney (SPK) transplantation is an inestimable procedure to enhance the quality of life of insulin-dependent patients with advanced renal disease. The creation of vascular anastomoses of the donor’s pancreas vessels to the recipient’s, is of utmost importance to predict the graft prognosis and surgical complications. In the study we introduce a novel technique for arterial reconstruction during SPK transplantation. Methods Conventionally, during the SPK transplantation, a so-called Y-graft is anastomosed between donor’s superior mesenteric and splenic artery to the recipient’s right iliac artery. In the study we adopted a new technique by preparing an extra extension using the donor’s carotid artery, to be anastomosed to the Y-graft and the iliac artery. In this non-blinded randomized clinical trial we compared the surgical complications and early outcomes between the 2 groups of patients with the traditional and new arterial reconstruction techniques during 3 months after transplantation Results Thirty adult patients were included in the study. The incidence of pancreatitis, vascular thrombosis and surgical site infection was lower in the new Y-graft and extension technique, which was not statistically significant. However, the calculated Cohen’s d index showed the medium effect of new Y-graft and extension technique on complication after SPK transplantations. Conclusion The post-operative complications tend to be lower in the novel arterial reconstruction technique, however a study on a larger patient group is encouraged to confirm our primary results. Trial registration: The study was registered at the Iranian Registry of Clinical Trials on 12/05/2022; IRCT 20210625051701N2; (http://www.irct.ir/).
Databáze: OpenAIRE